e-learning
resources
Vienna 2003
Monday 29.09.2003
Respiratory structure & function: clinical
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Evaluation of excited lung gas volume measurements in animals with genetic developing or developed emphysema or with induced panacinar emphysema
A. H. Jansson, A. Smailagic, A. M. D. Andersson, T. Fehniger, X. Wang (Lund, Sweden)
Source:
Annual Congress 2003 - Respiratory structure & function: clinical
Session:
Respiratory structure & function: clinical
Session type:
Thematic Poster Session
Number:
1809
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
A. H. Jansson, A. Smailagic, A. M. D. Andersson, T. Fehniger, X. Wang (Lund, Sweden). Evaluation of excited lung gas volume measurements in animals with genetic developing or developed emphysema or with induced panacinar emphysema. Eur Respir J 2003; 22: Suppl. 45, 1809
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Observational cohort study of pulmonary exacerbations in alpha-1 antitrypsin deficiency
Panel discussion on ERS Statement – A core outcome set for clinical trials evaluating the management of COPD exacerbations
ERS statement: a core outcome set for clinical trials evaluating the management of COPD exacerbations
Related content which might interest you:
Ability for dynamic hyperinflation increases after bronchoscopic lung volume reduction in patients with severe emphysema.
Source: International Congress 2017 – Endoscopic lung volume reduction (EVLR) and targeted lung denervation (TLD)
Year: 2017
Automated volumetric quantification of lung emphysema: the effect of bronchiectasis and infectious lung destruction.
Source: Virtual Congress 2021 – Pulmonary neoplasia and related pathologies
Year: 2021
Unilateral lung volume reduction surgery in patients with homogenous distribution of pulmonary emphysema
Source: Eur Respir J 2005; 26: Suppl. 49, 491s
Year: 2005
Association of the transfer coefficient of the lung for carbon monoxide with emphysema progression in male smokers
Source: Eur Respir J 2011; 38: 1012-1018
Year: 2011
Effects of oxygen inhalation during exercise in patients with combined pulmonary fibrosis and emphysema (CPFE)
Source: Annual Congress 2010 - Gas exchange and paediatric exercise testing
Year: 2010
Paradoxically normal lung volume assessed by CXR and total lung capacity in patients with diffuse pulmondary fibrosis and additional emphysema
Source: Eur Respir J 2006; 28: Suppl. 50, 98s
Year: 2006
Effects of lung volume reduction surgery in hamsters with elastase-induced emphysema
Source: Eur Respir J 2002; 19: 422-428
Year: 2002
²Nonobstructive² emphysema of the lung
Source: Annual Congress 2007 - Lung function and therapy in obstructive lung diseases
Year: 2007
Elastase-induced emphysema: Species differences in markers of acute lung injury relate to the magnitude of emphysema development
Source: Annual Congress 2010 - Proteases and the matrix
Year: 2010
Specific gas volume (SVg) variations between different lung volumes in health and emphysema
Source: Annual Congress 2011 - Morphological and functional imaging in obstructive airway disease
Year: 2011
A new double-tracer gas single-breath washout to assess early cystic fibrosis lung disease
Source: Eur Respir J 2013; 41: 339-345
Year: 2013
Deposition of aerosols in the lung periphery of patients with lung emphysema
Source: Eur Respir J 2001; 18: Suppl. 33, 212s
Year: 2001
Mortality in combined pulmonary fibrosis and emphysema patients is determined by the sum of pulmonary fibrosis and emphysema
Source: ERJ Open Res, 7 (3) 00316-2021; 10.1183/23120541.00316-2021
Year: 2021
Determining why patients with idiopathic pulmonary fibrosis (IPF) have difficulty performing gas transfer
Source: Annual Congress 2013 –Airway calibre, airway challenge and assessment of oxygenation
Year: 2013
Unilateral treatment with lung volume reduction coils in patients with severe emphysema
Source: Annual Congress 2013 –Bronchoscopic treatment of COPD and asthma: where are we going?
Year: 2013
Bronchoscopic lung volume reduction interventions for severe emphysema
Source: International Congress 2016 – Vitamin D and asthma prevention, COPD screening, and bronchoscopic lung volume reduction in emphysema
Year: 2016
Gravity dependence of lung density and specific gas volume (SVg) assessed by CT in health and emphysema
Source: Annual Congress 2011 - Morphological and functional imaging in obstructive airway disease
Year: 2011
Relationships of airway and tissue mechanics to lung volume in developing mice
Source: Eur Respir J 2005; 26: Suppl. 49, 365s
Year: 2005
Bronchoscopic thermal vapour ablation therapy in the management of heterogeneous emphysema
Source: Eur Respir J 2012; 39: 1326-1333
Year: 2012
The minimal important difference for residual volume in patients with severe emphysema
Source: Eur Respir J 2012; 40: 1137-1141
Year: 2012
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept